Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MDxHealth (MDXH) Inventory (2020 - 2026)

MDxHealth has reported Inventory over the past 7 years, most recently at $7.4 million for Q1 2026.

  • For Q1 2026, Inventory changed N/A year-over-year to $7.4 million; the TTM value through Mar 2026 reached $7.4 million, changed N/A, while the annual FY2025 figure was $6.7 million, 74.23% up from the prior year.
  • Inventory was $7.4 million for Q1 2026 at MDxHealth, up from $6.7 million in the prior quarter.
  • Across five years, Inventory topped out at $7.4 million in Q1 2026 and bottomed at $2.3 million in Q4 2022.
  • The 5-year median for Inventory is $3.9 million (2024), against an average of $4.6 million.
  • Year-over-year, Inventory grew 19.42% in 2023 and then surged 74.23% in 2025.
  • Over 5 years, Inventory stood at $2.3 million in 2022, then grew by 19.42% to $2.8 million in 2023, then surged by 39.22% to $3.9 million in 2024, then surged by 74.23% to $6.7 million in 2025, then increased by 9.32% to $7.4 million in 2026.
  • The last three reported values for Inventory were $7.4 million (Q1 2026), $6.7 million (Q4 2025), and $3.9 million (Q4 2024) per Business Quant data.